Dr. Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its...

Kohli’s 74 Seals India’s Auckland Win as DLS Method Decides Series Opener
Sophie Devine Four-For Seals Scorchers Win as Women’s Big Bash League Battles Intensify
Hobart Hurricanes Host Melbourne Renegades in WBBL Match 9 at Hobart
Cyclone Murasu Weakens to Depression Over Telangana and Andhra, Heavy Rain Kills Two
Pensioners Face November 30 Deadline for Nationwide Digital Life Certificate Campaign 


















